Chromosome segregation errors: a double-edged sword - TI Pharma
Chromosome segregation errors: a double-edged sword - TI Pharma
Chromosome segregation errors: a double-edged sword - TI Pharma
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
1<br />
heterogeneity and might therefore be an important factor in structural instability 264 .<br />
4.2 Numerical Chromosomal Instability<br />
Another striking hallmark of cancer cells is the presence of an abnormal chromosome<br />
number 236,265,266 , termed aneuploidy, a state in which cells do not contain an exact multiple<br />
of the haploid DNA content 267 . On average 25 percent of the genome of a cancer cell is affected<br />
by numerical changes of either whole chromosomes or complete chromosomal arms 243 .<br />
Aneuploidy can be stably inherited in a population of (tumor) cells 243,268,269 , but more often chromosome<br />
numbers continuously change between cancer cells and their offspring 270 . This continuous change in<br />
chromosome number is termed whole chromosomal instability (CIN) 231,270 and is associated with highgrade<br />
tumors, metastasis and poor prognosis 271-277 Moreover, CIN has been associated with resistance<br />
to chemotherapeutics, such as the widely used microtubule stabilizing agent Paclitaxel 278-280 . Various<br />
hypotheses have been postulated on how CIN and aneuploidy could contribute to tumorigenesis 281-285<br />
(see Discussion, Chapter 8). The general idea is that whole chromosome gains and losses during cell<br />
division can, as suggested above for structural changes, result in loss and gain of tumor suppressors and<br />
oncogenes respectively 286 , thereby providing a platform for cancer cells to adapt to their environment<br />
and continuously divide 287,288 .<br />
4.3 Causes of numerical CIN<br />
Since the initial discovery of chromosomal instability in a variety of colon cancer cell lines in 1997<br />
270 , many researchers have investigated the underlying cause of this striking phenotype, which was<br />
later found to be present in many other tumor types as well 243 231,289 . Several mechanisms have been<br />
proposed and tested using a variety of cancer cell lines and mouse models. However, it seems highly<br />
unlikely that one single mechanism can be held responsible for the CIN observed in the different types<br />
of tumors. Below we outline the different cellular causes that have been postulated and the genetic<br />
defects that could underlie these phenotypes.<br />
4.3.1 Mitotic checkpoint defects<br />
Defects in mitotic checkpoint signaling directly lead to chromosome mis<strong>segregation</strong>s (Fig.6A). Indeed,<br />
the hypothesis that has been investigated the most postulates that mitotic checkpoint defects could<br />
underlie CIN 290 . Complete mitotic checkpoint loss is lethal to all dividing cell types studied thus far and<br />
causes embryonic lethality 291-298 , likely because it results in continuous mis<strong>segregation</strong>s. Thus, even if<br />
a viable daughter cell is generated during a first cell division, its genome is not properly propagated<br />
in the subsequent cell division, resulting in growth arrest and cell death in the respective daughter<br />
cells 291-298 . In contrast, partial checkpoint dysfunction results in mild chromosome <strong>segregation</strong><br />
<strong>errors</strong>, which can potentially generate new viable genotypes that are relatively stable. Partial mitotic<br />
checkpoint activity could be responsible for this by allowing mitotic exit in the presence of one or<br />
more unattached kinetochores 291,298-300 . In line with this, CIN cancer cell lines were initially thought<br />
to have a weakened mitotic checkpoint due to mutations in the mitotic checkpoint kinase Bub1 301 .<br />
However, other researchers could not reproduce these checkpoint defects in the same CIN cell lines<br />
302 , which opened up the avenue for research on other possible causes of CIN. Although many CIN<br />
lines do not show a weakened mitotic checkpoint when challenged with microtubule-targeting agents<br />
302 , reduced levels or mutations in mitotic checkpoint genes have been identified in human cancer<br />
73,282,303-315 . In one specific syndrome, Mosaic Variegated Aneuploidy (MVA), which is linked to cancer<br />
20